Can Immunotherapy Cure Cancer Completely?
Immunotherapy can lead to complete and long-lasting cancer remission in some patients, but it never guarantees a cure for every type of cancer or is suitable for everyone. Results depend on factors such as cancer type, stage, tumour properties, biomarkers, and how the condition responds to the treatment. Doctors assess these factors to understand whether immunotherapy may be appropriate and how it may help in clinical practice.
Key Takeaways
- Immunotherapy helps the immune system recognise or attack cancer cells.
- Some patients experience complete responses or long-lasting remission, but outcomes vary.
- Checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, and cancer treatment vaccines work differently.
- Biomarker testing may help identify patients who are more likely to respond.
- Side effects can occur when immune activity affects healthy tissues.
- Immunotherapy may be used alone or alongside other cancer treatments.
Can Immunotherapy Cure Cancer Completely?
Can immunotherapy cure cancer completely? The answer depends on the cancer type, stage and individual response to treatment. Immunotherapy helps the immune system recognise or attack cancer cells, and some patients experience long-lasting remission. However, it does not work for everyone, and cancer can return even after a complete response.
Immunotherapy has expanded cancer treatment options by helping the immune system find and remove the cancer cells from the body. However, its effectiveness may vary based on the cancer type, disease stage and individual response.
While some patients may get full responses, others have partial responses where the tumour shrinks. In some instances, the cancer will come back even when treatment has yielded positive results. Knowledge of how immunotherapy is conducted, different kinds of immunotherapy, possible side effects, and results of treatment can assist patients and their families in making better decisions in consultation with oncologists.
What is Immunotherapy?
Immunotherapy is a type of cancer treatment that helps the patient’s body’s immune system find abnormal cancer cells. Although the immune system naturally identifies abnormal, unhealthy cells, cancer cells can sometimes escape detection or suppress the immune response, allowing them to grow independently.
Immunotherapy uses medicines or specially prepared immune cells to strengthen or redirect the body's response against cancer. This can be given:
- Injected straight into a vein
- As an injection beneath the skin
- Through application to the skin topically
- Taken orally as a tablet or capsule
While certain therapeutic strategies involve direct attacks on cancer cells, some forms of immunotherapy facilitate easier detection of cancer cells by immune cells. Others suppress those factors that inhibit immune cells from attacking the tumours. This largely depends upon the kind of immunotherapy administered and the nature of the cancer. Immunotherapy cannot be administered to all kinds of cancers.
What Are the Different Types of Immunotherapy?
Cancer immunotherapy has several types of treatments that help the immune system recognise and fight the cancer cells. The suitable choice depends on the cancer type, its characteristics, and whether a particular treatment is approved or suitable for that diagnosis.
1. Immune Checkpoint Inhibitors
This form of drugs works by stopping certain proteins that function as brakes on the immune system. It stops such proteins like PD-1, PD-L1 or CTLA-4. They have the ability to enhance the ability of T cells to detect and attack cancer cells.
2. CAR T-Cell Therapy
This is another type of immunotherapy that works by taking T cells from the body of the patient and then modifying them in the laboratory to fight against cancer cells. It’s normally used to treat certain blood cancers, although research is still being performed for solid tumours.
3. Monoclonal Antibodies
Monoclonal antibodies are simply laboratory-made proteins designed to attach to specific targets. Some help the immune system to find cancer cells present in the body, while others bring immune cells closer to unhealthy cells so they can fight them. Their uses often depend on the target and the type of cancer.
4. Vaccines for Treating Cancers
While most vaccines are meant to protect against diseases, cancer treatment vaccines are for people suffering from cancer. This vaccine stimulates the immune system to fight the cancer by targeting cancerous cells. Vaccines can be used in very few circumstances, but not all cancer vaccines are well-established treatments.
5. Immune System Modulators
These treatments strengthen or change aspects of the immune response. They include certain cytokines, immunomodulatory medicines and bacillus Calmette-Guérin (BCG), which is used for some bladder cancers. The effects and side effects vary depending on the medicine and its intended use.
How Does Immunotherapy Work Against Cancer?
Our immune system is present in the body to protect us from being attacked by unhealthy foreign substances that cause disease. The immune system can detect and destroy those abnormal cells, but sometimes cancer cells evade this detection, switch off immune cells or change their surroundings to slow down or weaken the responses.
Immunotherapy helps the immune system act more effectively against cancer. It works in different ways depending on the treatment.
Blocking Immune Checkpoints: These medicines remove signals that prevent immune cells from responding strongly to cancer.
Modifying Immune Cells: T-cell transfer therapy uses selected or slightly modified immune cells to strengthen their ability to fight back cancer cells.
Identification of Cancer Cells: Monoclonal antibodies may also be used for identification of cancer cells through their interaction with unique cancer cell receptors.
Boosting the Body's Immunity: Cancer treatment vaccines and immune system modulators help stimulate or enhance the body's response to cancer.
But there is always the chance that some cancer cells will manage to avoid attacks from the body’s immune system, which means that immunotherapy will not be effective in treating all patients.
What Are the Potential Benefits of Immunotherapy?
Immunotherapy has developed different treatment options for several cancers, including some advanced cancers. Its potential benefits may depend on the type of approach, cancer characteristics, and individual response.
Long-lasting Responses: In research, some patients experience durable responses, with cancer remaining under control for a long period.
Potential for Longer Survival: Some clinical studies have demonstrated improved survival in certain cancers, including advanced melanoma.
More Specific Immune Action: Some types of immunotherapy enhance immune system cells to detect certain cancer targets, but it could affect healthy tissues as well.
Other Treatments: Immunotherapy is used on its own or together with other treatments like chemotherapy, radiation, surgery, and target-specific therapy according to the type of cancer that was diagnosed.
But these results cannot be assured because there are some cases where the cancer does not react to the therapy or where the patient becomes resistant to it after being initially responsive.
What Are the Potential Risks and Side Effects of Immunotherapy?
Every potential approach has its own side effects. Immunotherapy may cause certain side effects when the activated immune system in the patient’s body starts attacking healthy cells and tissues alongside cancer cells. The effects may vary depending on the treatment type, dose and individual health.
Common side effects include:
Fatigue and Flu-like Symptoms: Some patients may feel tiredness, fever, chills and muscle aches.
Skin Reactions: In some cases, patients may come across rashes, itching, redness or swelling around an injection site.
Digestive Problems: May also feel nausea, vomiting or diarrhoea.
Organ Inflammation: In certain situations, there could be inflammation of the lungs, liver, intestines, heart, or hormone-producing organs.
However, in some situations, the side effects can turn dangerous or even life-threatening. Side effects might occur even after the treatment ends. Patients should promptly report new or worsening symptoms to their oncology team rather than trying to manage them independently.
Looking Ahead
Immunotherapy can provide lasting cancer control for some patients, but outcomes vary, and a complete response does not always mean a permanent cure. Patients should discuss treatment options, expected outcomes and potential risks with their oncologist.Stem cell therapy is not an established substitute for standard cancer immunotherapy. Anyone considering a stem cell-based approach alongside cancer care should seek independent medical guidance and review the evidence and regulatory status of the proposed therapy.
Frequently Asked Questions
Q1. Does immunotherapy work for every type of cancer?
No. Immunotherapy is used for specific cancers and clinical situations. Its suitability depends on the cancer type, stage, biomarkers and previous treatments.
Q2. Can immunotherapy provide long-term cancer remission?
Yes. Some patients experience durable responses or long-term remission, but others do not respond or may experience cancer recurrence. Outcomes vary by diagnosis and treatment.
Q3. What side effects can immunotherapy cause?
Common side effects include fatigue, skin reactions, fever and diarrhoea. Some treatments can also cause inflammation affecting organs such as the lungs, liver or intestines.
Q4. How do doctors determine whether immunotherapy is suitable?
Doctors consider the cancer type and stage, biomarker or genetic test results, previous treatments and overall health. Not every patient is eligible for every immunotherapy.
Q5. Can immunotherapy be combined with other cancer treatments?
Yes. Depending on the diagnosis, immunotherapy may be combined with chemotherapy, radiation, surgery or targeted therapy. The appropriate combination depends on clinical evidence and the patient's circumstances.
References
(1) Wolchok JD, et al. (2025). Final 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. New England Journal of Medicine, 392, 11–22.
Retrieved from:https://doi.org/10.1056/NEJMoa2407417
(2) Waldman AD, Fritz JM, Lenardo MJ. (2020). A Guide to Cancer Immunotherapy: From T Cell Basic Science to Clinical Practice. Nature Reviews Immunology, 20, 651–668.
Retrieved from:https://doi.org/10.1038/s41577-020-0306-5
(3) Arnaud-Coffin P, et al. (2019). A Systematic Review of Adverse Events in Randomised Trials Assessing Immune Checkpoint Inhibitors. International Journal of Cancer, 145(3), 639–648.
Retrieved from:https://pubmed.ncbi.nlm.nih.gov/30653255/
(4) Burstein HJ, et al. (2023). Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. Journal of Clinical Oncology.
Retrieved from:https://doi.org/10.1200/JCO.22.01063
(5) Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. (2016). The Future of Cancer Treatment: Immunomodulation, CARs and Combination Immunotherapy. Nature Reviews Clinical Oncology, 13, 273–290.
Retrieved from:https://doi.org/10.1038/nrclinonc.2016.25
(6) National Cancer Institute. Immunotherapy to Treat Cancer. National Institutes of Health.
Retrieved from:https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
(7) American Institute for Cancer Research. (2025). Immunotherapy for Cancer: How It Works, Benefits and What’s Next.
Retrieved from: https://www.aicr.org/resources/blog/immunotherapy-for-cancer-how-it-works-benefits-and-whats-next/
(8) Cancer Research Institute. Immunotherapy for Your Cancer Type.
Retrieved from: https://www.cancerresearch.org/immunotherapy-by-cancer-type
Medical Disclaimer
This blog is for educational purposes only and does not replace professional medical advice, diagnosis or treatment. Consult a qualified oncologist before making decisions about cancer treatment. Always discuss the safety, evidence and regulatory status of any proposed therapy with your healthcare team.